| 1 |
33124053 | Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia. | 2021 Jun |
1 |
| 2 |
34636169 | NUDT15 polymorphism and NT5C2 and PRPS1 mutations influence thiopurine sensitivity in acute lymphoblastic leukaemia cells. | 2021 Nov |
1 |
| 3 |
30910786 | Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL. | 2019 May 23 |
1 |
| 4 |
31648313 | Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets. | 2019 Oct 22 |
1 |
| 5 |
29342136 | Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. | 2018 Jan 25 |
4 |
| 6 |
29990496 | Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia. | 2018 Jul 9 |
1 |
| 7 |
25656700 | The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor. | 2015 Mar 15 |
1 |
| 8 |
23377281 | Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. | 2013 Mar |
1 |